Glaukos Corp (GKOS): Cost of Revenue
$111.81M
Year ended 2025-12-31
$127.96M
Trailing 12 months to 2026-06-30
+17.5%
3-year compound annual growth
+4.0%
5-year compound annual growth
+24.0%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $111.81M | +18.9% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | $94.03M | +24.4% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | $75.58M | +9.6% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | $68.98M | +3.5% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $66.63M | -27.4% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $91.72M | +137.7% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $38.59M | +53.9% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $25.07M | +19.1% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $21.05M | +30.1% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $16.18M | +24.6% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $12.99M | +13.8% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $11.42M | +350.4% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $2.54M | n/a | 2016-03-15, From 2013-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Glaukos Corp (GKOS) | 2025-12-31 | $111.81M | +18.9% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $133.75M | +13.6% |
| Bioventus Inc. (BVS) | 2025-12-31 | $179.93M | -2.8% |
| Artivion, Inc. (AORT) | 2025-12-31 | $157.10M | +12.4% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $432.39M | +20.9% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $73.01M | +21.5% |
| Accuray Inc (ARAY) | 2026-06-30 | $290.49M | -6.8% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $166.88M | +21.6% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $219.89M | +19.3% |
Compare GKOS, ATRC, BVS, AORT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗